Accès ouvert
2022
article
OpenAlex
Katherine Dewey, Bo Yen, Jose Lazo, Leslie Seijo et autres
BACKGROUND: Limited data and guidelines exist for using nirmatrelvir/ritonavir in solid organ transplant recipients stabilized on tacrolimus for the treatment of mild-to-moderate coronavirus disease. Concern exists regarding the impact of utilizing a 5-d course of nirmatrelvir/ritonavir with calcineurin inhibitors because of significant …
us
(code pays fourni par la source)
Accès ouvert
2021
article
OpenAlex
Tyler Maxwell, James E Orban, Wesley D. Kufel, Christopher J. Destache et autres
Abstract Background Daptomycin (DAP) has become an appealing treatment option for gram-positive infections, which are common in patients receiving hemodialysis (HD), due to frequent access and manipulation. The approved DAP dosing of 4 to 6 mg/kg every 48 hours (q48h) quickly becomes …
us
(code pays fourni par la source)
Accès ouvert
2020
article
OpenAlex
Pranay Sinha, S. Reza Jafarzadeh, Sabrina A. Assoumou, Catherine Bielick et autres
BACKGROUND: The effectiveness of interleukin-6 inhibitors (IL-6i) in ameliorating coronavirus disease 2019 (COVID-19) remains uncertain. METHODS: We analyzed data for patients aged ≥18 years admitted with a positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test at 4 safety-net hospital …
us
(code pays fourni par la source)
Accès ouvert
2016
article
OpenAlex
Bethanne Carpenter, Erin Hennessey, Alex Bryant, Jad A. Khoury et autres
PURPOSE: Recurrent Clostridium difficile infection (RCDI) is a growing concern, yet limited data exists to clarify which patients are at highest risk. Identification of these patients may better inform decisions of those who may benefit from prophylactic intervention. The purpose of this …
us
(code pays fourni par la source)
Accès ouvert
2014
conference-abstract
OpenAlex
Ryan P Moenster, Travis W Linneman, Bethanne Carpenter, Stephanie Tackett
Background. Enterococcus remains the second most frequently isolated organism from the urine of hospitalized patients. With as many as 30% of all enterococcal isolates resistant to vancomycin, treatment options are limited. Methods. A retrospective cohort study was conducted of all patients at …
us
(code pays fourni par la source)